Dec 14 (Reuters) - Actinogen Medical Ltd (ACW) :
- ACTINOGEN ANNOUNCES FIRST PATIENT TREATED IN DEPRESSION AND COGNITIVE IMPAIRMENT PHASE 2 CLINICAL TRIAL
News: ACW Actinogen Announces First Patient Treated In Depression Drug Trial
- There are more pages in this discussion • 6 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add ACW (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
3.2¢ |
Change
-0.006(15.8%) |
Mkt cap ! $74.46M | |||
| Open | High | Low | Value | Volume |
| 3.0¢ | 3.4¢ | 2.9¢ | $186.2K | 6.157M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 189149 | 3.2¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 3.4¢ | 621429 | 4 |
View Market Depth
| Last trade - 15.52pm 03/05/2024 (20 minute delay) ? |
|
|||||
|
Last
3.2¢ |
Change
-0.006 ( 11.1 %) |
||||
| Open | High | Low | Volume | ||
| 3.0¢ | 3.4¢ | 2.9¢ | 3278602 | ||
| Last updated 15.52pm 03/05/2024 ? | |||||
| ACW (ASX) Chart |